XML 26 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Income Taxes
12 Months Ended
Dec. 31, 2017
Income Tax Disclosure [Abstract]  
Income Taxes
INCOME TAXES
The following schedule discloses significant components of income tax expense (benefit) for each year presented:
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
 
(in thousands)
Current tax expense (benefit):
 
 
 
 
 
 
U.S. Federal
 
$
(52,501
)
 
$
(99,443
)
 
$
105,992

State and local
 
0

 
49

 
129

Total
 
(52,501
)
 
(99,394
)
 
106,121

Deferred tax expense (benefit):
 
 
 
 
 
 
U.S. Federal
 
(102,153
)
 
25,525

 
(116,762
)
Total
 
(102,153
)
 
25,525

 
(116,762
)
Total income tax expense (benefit)
 
(154,654
)
 
(73,869
)
 
(10,641
)
Total income tax expense (benefit) reported in equity related to:
 
 
 
 
 
 
Other comprehensive income (loss)
 
43,372

 
3,322

 
(61,322
)
Additional paid-in capital
 
824

 
587

 
(6,560
)
Total income tax expense (benefit)
 
$
(110,458
)
 
$
(69,960
)
 
$
(78,523
)

Reconciliation of Expected Tax at Statutory Rates to Reported Income Tax Expense (Benefit)
The differences between income taxes expected at the U.S. federal statutory income tax rate of 35% and the reported income tax expense (benefit) are summarized as follows:
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
 
(in thousands)
Expected federal income tax expense
 
$
59,591

 
$
112,472

 
$
174,077

Non-taxable investment income
 
(157,408
)
 
(146,324
)
 
(161,407
)
Tax credits
 
(29,506
)
 
(30,916
)
 
(24,232
)
Domestic production activities deduction, net
 
(10,448
)
 
(9,488
)
 
0

Changes in tax law
 
(17,576
)
 
0

 
0

Other
 
693

 
387

 
921

Reported income tax expense (benefit)
 
$
(154,654
)
 
$
(73,869
)
 
$
(10,641
)
Effective tax rate
 
(90.8
)%
 
(22.9
)%
 
(2.1
)%

The effective tax rate is the ratio of “Total income tax expense (benefit)” divided by “Income (loss) from operations before income taxes and equity in earnings of operating joint venture.” The Company’s effective tax rate for fiscal years 2017, 2016 and 2015 was (90.8)%, (22.9)% and (2.1)%, respectively. The following is a description of items that had the most significant impact on the difference between the Company’s statutory U.S. federal income tax rate of 35% and the Company’s effective tax rate during the periods presented:
Changes in Tax Law. The following is a list of notable changes in tax law that impacted the Company’s effective tax rate for the periods presented:
U.S. Tax Cuts and Jobs Act of 2017 (“Tax Act of 2017”). On December 22, 2017, the Tax Act of 2017 was enacted into U.S. law. This law includes a broad range of tax reform changes that will affect U.S. businesses, including changes to corporate tax rates, business deductions and international tax provisions. Under U.S. GAAP, changes in tax rates and tax law are accounted for in the period of enactment (the date the President signed the bill into law).
In December 2017, the SEC staff issued SAB 118 to address the application of U.S. GAAP in situations when a registrant does not have necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the Tax Act of 2017. SAB 118 provides guidance for registrants under three scenarios: (1) measurement of certain income tax effects is complete, (2) measurement of certain income tax effects can be reasonably estimated and (3) measurement of certain income tax effects cannot be reasonably estimated. SAB 118 provides that the measurement period is complete when a company’s accounting is complete and in no circumstances should the measurement period extend beyond one year from the enactment date. SAB 118 acknowledges that a company may be able to complete the accounting for some provisions earlier than others. As a result, it may need to apply all three scenarios in determining the accounting for the Tax Act of 2017 based on information that is available.
The Company has not fully completed its accounting for the tax effects of the Tax Act of 2017. However, we have recorded the effects of the Tax Act of 2017 as reasonable estimates due to the need for further analysis of the provisions within the Tax Act of 2017 and collection, preparation and analysis of relevant data necessary to complete the accounting. As a result, upon enactment of the Tax Act of 2017, the Company recognized a $17.6 million tax benefit in “Total income tax expense (benefit)” in the Company’s Consolidated Statements of Operations for the year ended December 31, 2017. This net tax benefit was comprised of the following component:
$17.6 million tax benefit from the reduction in net deferred tax liabilities to reflect the reduction in the U.S. tax rate from 35% to 21%
As we complete the collection, preparation and analysis of data relevant to the Tax Act of 2017, interpret any additional guidance issued by the IRS, U.S. Department of the Treasury, or other standard-setting organizations, we may make adjustments to these provisional amounts. These adjustments may materially impact our provision for income taxes in the period in which the adjustments are made.
Non-Taxable Investment Income. The U.S. Dividends Received Deduction (“DRD”) reduces the amount of dividend income subject to U.S. tax and accounts for most of the non-taxable investment income shown in the table above. More specifically, the U.S. DRD constitutes $155 million of the total $157 million of 2017 non-taxable investment income, $142 million of the total $146 million of 2016 non-taxable investment income, and $161 million of the total $161 million of 2015 non-taxable investment income. The DRD for the current period was estimated using information from 2016, current year investment results, and current year’s equity market performance. The actual current year DRD can vary based on factors such as, but not limited to, changes in the amount of dividends received that are eligible for the DRD, changes in the amount of distributions received from fund investments, changes in the account balances of variable life and annuity contracts, and the Company’s taxable income before the DRD.
Other. This line item represents insignificant reconciling items that are individually less than 5% of the computed expected federal income tax expense (benefit) and have therefore been aggregated for purposes of this reconciliation in accordance with relevant disclosure guidance.
Schedule of Deferred Tax Assets and Deferred Tax Liabilities
 
 
As of December 31,
 
 
2017
 
2016
 
 
(in thousands)
Deferred tax assets:
 
 
 
 
Insurance reserves
 
$
171,504

 
$
148,115

Other
 
0

 
1,966

Deferred tax assets
 
171,504

 
150,081

Deferred tax liabilities:
 
 
 
 
Deferred policy acquisition costs
 
39,501

 
45,405

Net unrealized gains on securities
 
61,294

 
24,949

Investments
 
96,385

 
171,303

Other
 
7,944

 
0

Deferred tax liabilities
 
205,124

 
241,657

Net deferred tax asset (liability)
 
$
(33,620
)
 
$
(91,576
)

The application of U.S. GAAP requires the Company to evaluate the recoverability of deferred tax assets and establish a valuation allowance if necessary to reduce the deferred tax asset to an amount that is more likely than not expected to be realized. Considerable judgment is required in determining whether a valuation allowance is necessary, and if so, the amount of such valuation allowance. In evaluating the need for a valuation allowance, the Company considers many factors, including: (1) the nature of the deferred tax assets and liabilities; (2) whether they are ordinary or capital; (3) in which tax jurisdictions they were generated and the timing of their reversal; (4) taxable income in prior carryback years as well as projected taxable earnings exclusive of reversing temporary differences and carryforwards; (5) the length of time that carryovers can be utilized in the various taxing jurisdictions; (6) any unique tax rules that would impact the utilization of the deferred tax assets; and (7) any tax planning strategies that the Company would employ to avoid a tax benefit from expiring unused. Although realization is not assured, management believes it is more likely than not that the deferred tax assets, net of valuation allowances, will be realized.
The Company had no valuation allowance as of December 31, 2017 and 2016. Adjustments to the valuation allowance will be made if there is a change in management’s assessment of the amount of deferred tax asset that is realizable.
The Company’s “Income (loss) from operations before income taxes and equity in earnings of operating joint venture” includes income from domestic operations of $170 million, $321 million and $497 million for the years ended December 31, 2017, 2016 and 2015, respectively.
Tax Audit and Unrecognized Tax Benefits
The Company’s liability for income taxes includes the liability for unrecognized tax benefits and interest that relate to tax years still subject to review by the IRS or other taxing authorities. The completion of review or the expiration of the Federal statute of limitations for a given audit period could result in an adjustment to the liability for income taxes.
The following table reconciles the total amount of unrecognized tax benefits at the beginning and end of the periods indicated.
 
 
2017
 
2016
 
2015
 
 
(in thousands)
Balance at January 1,
 
$
9,488

 
$
0

 
$
0

Increases in unrecognized tax benefits-prior years
 
12,373

 
4,744

 
0

(Decreases) in unrecognized tax benefits-prior years
 
0

 
0

 
0

Increases in unrecognized tax benefits-current year
 
8,335

 
4,744

 
0

(Decreases) in unrecognized tax benefits-current year
 
0

 
0

 
0

Settlements with taxing authorities
 
0

 
0

 
0

Balance at December 31,
 
$
30,196

 
$
9,488

 
$
0

Unrecognized tax benefits that, if recognized, would favorably impact the effective rate
 
$
30,196

 
$
9,488

 
$
0


The Company does not anticipate any significant changes within the next twelve months to its total unrecognized tax benefits related to tax years for which the statute of limitations has not expired.
The Company classifies all interest and penalties related to tax uncertainties as income tax expense (benefit).
At December 31, 2017, the Company remains subject to examination in the U.S. for tax years 2014 through 2016.
The Company is participating in the IRS’s Compliance Assurance Program. Under this program, the IRS assigns an examination team to review completed transactions as they occur in order to reach agreement with the Company on how they should be reported in the relevant tax returns. If disagreements arise, accelerated resolution programs are available to resolve the disagreements in a timely manner before the tax returns are filed.